Nonoperative Options for Management of Articular Cartilage Disease

https://doi.org/10.1016/j.csm.2017.02.003Get rights and content

Section snippets

Key points

  • Low-impact exercise and weight loss are beneficial for osteoarthritis of weight-bearing joints.

  • Judicious use of nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen can be appropriate for pain management.

  • Topical NSAIDs may be a treatment option with fewer side effects than their oral counterpart.

  • Viscosupplementation injections are useful for mild to moderate knee osteoarthritis.

  • Corticosteroid injections are useful for short-term pain relief.

Oral medications: acetaminophen, nonsteroidal anti-inflammatory drugs, opioids

When patients are no longer experiencing sufficient symptom relief from nonpharmacologic methods, either oral or topical analgesics are typically initiated as an adjunctive therapy. A logical first choice is acetaminophen due to greater safety and a lower side-effect profile than nonsteroidal anti-inflammatory drugs (NSAIDs). As such, it is consistently recommended as a first-line pharmacologic treatment option.1 There is low-level evidence on the effectiveness of acetaminophen for OA pain in

Topicals: nonsteroidal anti-inflammatory drugs, lidocaine, capsaicin

Another option for patients who want to try pharmacologic treatment but wish to minimize systemic effects is topical therapy. Topical treatments deliver local analgesic effects with minimal systemic absorption. Options include topical NSAIDs, such as diclofenac, lidocaine, and capsaicin. A 2016 Cochrane review evaluated 33 RCTs on topical NSAIDs for chronic musculoskeletal pain due to OA.20 In studies ranging 6 to 12 weeks, 60% of patients had a significant decrease in pain compared with

Supplements: glucosamine, chondroitin, others

Many patients with articular cartilage disease wishing to avoid traditional pharmacologic treatments or their associated side effects turn to over-the-counter supplements. Two of the most commonly used supplements are glucosamine and chondroitin sulfate, either alone or in combination. The estimated $810 million US consumer market for the 2 supplements in 2005 demonstrates the extent of use.22 The rationale behind glucosamine use is related to its presence in human articular cartilage.

Steroid injections

Although it has been described as a degenerative process, current understanding of the pathophysiology of OA involves a cascade of inflammatory mediators in the joint. Corticosteroid injections are performed with the intention of reducing pain and improving function by producing a powerful local anti-inflammatory effect.31 The effects of corticosteroid injections are most notable in the short term, resulting in significant decreases in pain.2 This makes steroid injections a reasonable option

Viscosupplementation

Viscosupplementation is a technique that involves the injection of exogenous high molecular weight hyaluronic acid molecules to combat the effect of the decreased viscoelasticity of synovial fluid seen in OA.37 It is typically the second-line choice for injection therapy if the effectiveness of corticosteroids is limited. It is also used without prior corticosteroid injections for younger, physically active patients. Viscosupplementation is a good alternative in situations in which

Prolotherapy (and biologics)

Prolotherapy is an injection technique that uses nonbiologic irritant solutions, most commonly dextrose.43 The mechanism of action is multifactorial and not well understood, but proposed mechanisms include stimulation of a local healing process in tissue with chronic damage, decreasing joint instability by increasing the strength of tendons and ligaments, and stimulating cell proliferation.44 Animal studies have suggested cartilage-specific anabolic growth. A recent small study used

Summary

Nonoperative options for articular cartilage injury are omnipresent but have not shown to be curative. Recommendations for low-impact exercise and weight loss provide benefit and are a foundation for the treatment of OA. Many options are available to manage the pain associated with OA and their use should be based on an individualized consideration of the risks and benefits afforded the patient. Future studies to individualize treatment options based on patient phenotype and genotype may hold

First page preview

First page preview
Click to open first page preview

References (46)

  • M. Fransen et al.

    Exercise for osteoarthritis of the knee

    Cochrane Database Syst Rev

    (2015)
  • M. Fransen et al.

    Exercise for osteoarthritis of the hip

    Cochrane Database Syst Rev

    (2014)
  • E.M. Bartels et al.

    Aquatic exercise for the treatment of knee and hip osteoarthritis

    Cochrane Database Syst Rev

    (2016)
  • R. Christensen et al.

    Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis

    Ann Rheum Dis

    (2007)
  • R. Christensen et al.

    Effect of weight maintenance on symptoms of knee osteoarthritis in obese patients: a twelve-month randomized controlled trial

    Arthritis Care Res (Hoboken)

    (2015)
  • S.P. Messier et al.

    Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial

    JAMA

    (2013)
  • A. Anandacoomarasamy et al.

    Weight loss in obese people has structure-modifying effects on medial but not on lateral knee articular cartilage

    Ann Rheum Dis

    (2012)
  • I. Svege et al.

    Exercise therapy may postpone total hip replacement surgery in patients with hip osteoarthritis: a long-term follow-up of a randomised trial

    Ann Rheum Dis

    (2015)
  • T. Duivenvoorden et al.

    Braces and orthoses for treating osteoarthritis of the knee

    Cochrane Database Syst Rev

    (2015)
  • T.E. Towheed et al.

    Acetaminophen for osteoarthritis

    Cochrane Database Syst Rev

    (2006)
  • R.R. Bannuru et al.

    Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis

    Ann Intern Med

    (2015)
  • N. Bhala et al.

    Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

    Lancet

    (2013)
  • B.R. da Costa et al.

    Oral or transdermal opioids for osteoarthritis of the knee or hip

    Cochrane Database Syst Rev

    (2014)
  • Cited by (9)

    • Orthoses for knee dysfunction

      2019, Orthotics and Prosthetics in Rehabilitation
    • Nutraceuticals and osteoarthritis pain

      2018, Pharmacology and Therapeutics
      Citation Excerpt :

      Pharmacological agents reducing the levels of these pro-inflammatory mediators may therefore aid in OA pain relief and reverse the neurophysiological processes generated during OA pain pathogenesis (Hunter et al., 2009). Physical therapy and moderate exercise for weight loss and improved muscle strength are examples of noninvasive, non-pharmacological treatments aimed at reducing OA pain (Poddar & Widstrom, 2017). Oral and topical NSAIDs are widely regarded as first-line pharmacological treatments for OA pain (Hochberg, et al., 2012).

    • Magnetic hydrogel applications in articular cartilage tissue engineering

      2024, Journal of Biomedical Materials Research - Part A
    • Advanced injectable hydrogels for cartilage tissue engineering

      2022, Frontiers in Bioengineering and Biotechnology
    • Cartilage Defects in the Knee: Clinical, Imaging, and Treatment Aspects

      2021, Principles of Orthopedic Practice for Primary Care Providers: Second Edition
    View all citing articles on Scopus

    Disclosure Statement: The authors have nothing to disclose.

    View full text